Flow Diversion Aneurysm Treatment Market By Product (SURPASS Flow Diverter, SILK Flow Diverter Pipeline Embolization Device), End-user (Specialty Clinics, Hospitals), Industry Trends, Estimation & Forecast, 2017 – 2025

Flow Diversion Aneurysm Treatment market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Market Overview:

In flow diversion aneurysm the treatment is carried out by means of an endovascular technique using flow diverters. In such endovascular technique the placement of device is done in the parent blood vessel to divert the flow of blood away from aneurysm itself. Due to rapid enhancements in clinical results the aneurysm market has emerged out to be highly safe and effective in the treatment of distal anterior circulation aneurysms, ruptured aneurysms and posterior circulation aneurysms. The treatment done using flow diverters is minimally invasive in nature and is majorly used in treating intracranial aneurysm. The increasing prevalence of aneurysm in aging population and increasing focus of universities and research institutes towards developing flow diverters are some of the major factors propelling the growth of the global market. Moreover, growing demand for minimally invasive surgeries which helps in reducing duration of hospital stay, enabling patient to recover, is also a major contributing agent, driving the growth of the very market. According to National Center of Biotechnology, the worldwide prevalence of intracranial aneurysms is estimated to be in between 5% to 10% as per the demographic variations. On the other hand due the presence of alternative methods such as neurovascular embolization coiling and surgical clipping which are used for the treatment of both un-ruptured and ruptured intracranial aneurysm is hampering the expansion of the global market. Other factors such as stringent government regulations, risk of complications and high cost of treatment in flow diversion aneurysm are also inhibiting the growth of the market. Introduction of new flow diverters with affordable costs and increasing research and development activities for assessing relations of several aneurysms are expected to provide lucrative opportunities for growth of the global flow diversion aneurysm treatment market. The market of flow diversion aneurysm treatment is moderately fragmented in nature due to the presence of few global market players. The report provides detailed qualitative and quantitative analysis of the Flow Diversion Aneurysm Treatment Market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely product and end user in each of the major regions.

Flow Diversion Aneurysm Treatment Market Segmentation

By Product •SURPASS Flow Diverter •SILK Flow Diverter •Pipeline Embolization Device By End-user •Specialty Clinics •Hospitals By Geography •North America oU.S. oCanada oMexico •Europe oU.K. oFrance oGermany oItaly oSpain oRest of Europe •Asia-Pacific oChina oJapan oIndia oKorea oRest of APAC •South America oBrazil oRest of South America •Rest of the World oMiddle East oAfrica

•InspireMD
•MicroVention
•Phenox
•Balt Extrusion
•Stryker
•Medtronic
•Acandis

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS